GlassScriptPhysician profile
Alon Yarkoni
NPI 1912103052
$107,789.19
in general payments reported to CMS, 2019-2025
55 companies · $25K in 2025
The $25K reported for 2025 was more than what 94% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $5,373 · 2021: $7,114 · 2022: $14K · 2023: $16K · 2024: $20K · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $35K · Travel and Lodging: $23K · Consulting Fee: $2,940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $35,302.02 |
| Travel and Lodging | $23,245.26 |
| Consulting Fee | $2,940.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $53,843.10 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $8,767.10 | 2019-2025 | Navitor, Triclip, Mitraclip |
| Inari Medical, INC. | $7,694.14 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $5,302.79 | 2021-2025 | Corevalve Evolut R, Reveal Linq |
| Abiomed | $3,646.88 | 2019-2025 | Impella |
| Penumbra, INC. | $3,633.33 | 2020-2022 | |
| Philips North America LLC | $2,657.01 | 2019-2025 | Coronary Other, Coronary Undivided, Igt Devices Undivided |
| Medtronic Vascular, INC. | $2,066.94 | 2019-2020 | |
| Biotronik INC. | $1,655.96 | 2019-2025 | Orsiro Mission, Biomonitor, Recross |
| Pfizer INC. | $1,564.15 | 2019-2025 | |
| Boston Scientific Corporation | $1,552.17 | 2019-2025 | Watchman Flx, Watchman Access System, Sentinel |
| Janssen Pharmaceuticals, INC | $1,552.05 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $1,475.78 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,437.75 | 2019-2025 | Farxiga, Wainua, Brilinta |
| E.R. Squibb & Sons, L.L.C. | $1,409.38 | 2019-2025 | Camzyos, Eliquis |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,347.96 | 2019-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $1,180.57 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,047.92 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $817.43 | 2021-2025 | Verquvo |
| Stryker Corporation | $766.86 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Chiesi USA, INC. | $737.38 | 2019-2025 | Kengreal, Cleviprex, Juxtapid |
| W. L. Gore & Associates, INC. | $486.24 | 2019-2025 | Gore Cardioform Septal Occluder |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $419.95 | 2019-2023 | Lifevest |
| Cardiovascular Systems INC. | $286.66 | 2022-2023 | |
| Amarin Pharma, INC. | $270.35 | 2019-2022 | |
| Medicomp INC | $212.55 | 2022-2025 | Telepatch Cardiac Monitor |
| Angiodynamics, INC. | $200.33 | 2021-2025 | Alphavac |
| Heartflow, INC. | $167.62 | 2023-2025 | Ffrct |
| Novo Nordisk INC | $155.39 | 2023-2025 | Wegovy |
| Lexicon Pharmaceuticals, INC. | $148.31 | 2023-2024 | Inpefa |
| Teleflex LLC | $139.44 | 2023-2025 | Orsiro Mission, Raider |
| Recor Medical INC | $107.48 | 2024 | Paradise Renal Denervation System |
| Kiniksa Pharmaceuticals International, Plc | $102.03 | 2024 | Arcalyst |
| Bridgebio Pharma, INC. | $99.26 | 2025 | Attruby |
| Shape Memory Medical INC. | $91.12 | 2025 | Impede Embolization Plug |
| Alnylam Pharmaceuticals INC. | $71.08 | 2019-2024 | Onpattro |
| Daiichi Sankyo INC. | $63.18 | 2023-2024 | Injectafer |
| Biosense Webster, INC. | $54.05 | 2023-2024 | Na, Soundstar, Nuvision Ice Catheter |
| Gilead Sciences, INC. | $53.33 | 2019 | |
| Impulse Dynamics (USA) INC. | $51.20 | 2023 | Optimizer |
| Astellas Pharma US INC | $49.65 | 2019 | |
| Becton, Dickinson and Company | $48.91 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $44.88 | 2022-2023 | Evkeeza |
| Akcea Therapeutics, INC. | $39.69 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $36.86 | 2019-2024 | Uptravi |
| Kiniksa Pharmaceuticals, LTD. | $36.84 | 2023 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $32.88 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $26.19 | 2019 | |
| Haemonetics Corporation | $24.06 | 2022 | |
| Kestra Medical Technology Services, INC. | $22.35 | 2025 | Assure Wcd |
| Kls-Martin L.P. | $21.84 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $21.81 | 2019 | |
| Inspire Medical Systems, INC. | $18.74 | 2025 | Inspire |
| Alexion Pharmaceuticals, INC. | $14.90 | 2022 | |
| Portola Pharmaceuticals, LLC | $13.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,658.55 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alon Yarkoni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.